Home › Hemangiosarcoma › California
Hemangiosarcoma clinical trials in California
3 studies for Hemangiosarcoma are looking for participants at sites in California.
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
- USC/Norris Comprehensive Cancer Center, Los Angeles
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06440005Intratumoral Vusolimogene Oderparepvec (VO) in Combination With Pembrolizumab for Angiosarcoma
- University of California, San Francisco, San Francisco
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 1, 2026 · NCT06898970I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
- University of California - Davis, Comprehensive Cancer Center, Davis
- City of Hope, Duarte
- University of California San Diego, La Jolla
- and 3 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 6, 2026 · NCT01042379From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.